InvestorsHub Logo
icon url

Jackxkr

02/21/23 8:53 PM

#569721 RE: Maverick0408 #569720

Funny thing is you can't get pumpers to even consider that under different mgmt that there is even the smallest of chances thst nwbo would be further ahead. They are like trumps chumps who don't see him as being all about him but somehow see him as being a champion of days gone by. Mgmt is to old and not dialed in .
icon url

hoffmann6383

02/21/23 9:04 PM

#569735 RE: Maverick0408 #569720

Why they didn’t use CRL or other CDMO in UK to get MHRA approvals last year is beyond me!



Utter nonsense. We didn't have the PIP approved a year ago and they are still working on the Master File at the time of the ASM. A possible submission last year is another bear narrative lacking any facts that again tries to point the finger at management and cast them in a disparaging light.

Have a good one Mav!
Bullish
Bullish
icon url

Poor Man -

02/21/23 9:06 PM

#569738 RE: Maverick0408 #569720

Bingo, Mav.

The prayer is whether or not this company survives long enough to bring in a Pharma partner.

This is unfortunately not going anywhere until they bring a big pharma partner on board. MIA will definitely be perceived as meh unless it’s accompanied by some other surprise such as FDA BLA news or UK regulatory approval coupled with an update on NICE timing.
Until then we will continue to get diluted at .60s

It’s called exploiting conflicts of interest. And it’s bad for shareholders and patients alike.

Why they didn’t use CRL or other CDMO in UK to get MHRA approvals last year is beyond me!This way, they wouldn’t have had to wait for Advent to catch up with commercial certifications.

icon url

dennisdave

02/22/23 4:51 AM

#569830 RE: Maverick0408 #569720

Why they didn’t use CRL or other CDMO in UK to get MHRA approvals last year is beyond me! This way, they wouldn’t have had to wait for Advent to catch up with commercial certifications. They could have also made progress with FDA BLA application and could have gotten BLA accepted last year with CRL as a manufacturing partner.



I have been saying that for months.
The disadvantage of another CDMO such as CRL is that Linda and Toucan would not be able to start their own privately owned CDMO financed by NWBO shareholders never mind patients dying while waiting until Linda is done enriching herself (while talking to her therapist for being shell shocked). so there is that.